KPC Pharmaceuticals Inc (600422)

Currency in CNY
14.52
-0.05(-0.34%)
Delayed Data·
600422 Scorecard
Full Analysis
Trading at a low earnings multiple
600422 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
14.5114.58
52 wk Range
11.9218.64
Key Statistics
Bid/Ask
14.52 / 14.53
Prev. Close
14.57
Open
14.57
Day's Range
14.51-14.58
52 wk Range
11.92-18.64
Volume
845.1K
Average Volume (3m)
12.02M
1-Year Change
-3.26%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600422 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
21.83
Upside
+50.32%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

KPC Pharmaceuticals Inc Company Profile

KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People’s Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, specialty herbal, fine Chinese, and classic prescription for bones and joint, antibiotic, immunosuppressive, and others. The company provides medicine and food, skin care, oral care, private care, and time-honored food series; and other products, such as oral medication and injections. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. The company was founded in 1951 and is based in Kunming, the People’s Republic of China.

Employees
5275
Market
China

Compare 600422 to Peers and Sector

Metrics to compare
600422
Peers
Sector
Relationship
P/E Ratio
18.2x26.8x−0.5x
PEG Ratio
1.28−0.170.00
Price/Book
2.1x2.4x2.6x
Price / LTM Sales
1.4x3.1x3.3x
Upside (Analyst Target)
46.5%10.6%43.3%
Fair Value Upside
Unlock−5.8%6.9%Unlock

Analyst Ratings

7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 21.83
(+50.32% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.81%
Dividend Yield
2.06%
Industry Median 1.51%
Annualised payout
0.30
Paid unevenly
5-Years Growth
+8.45%
Growth Streak

Earnings

Latest Release
Apr 28, 2025
EPS / Forecast
0.12 / --
Revenue / Forecast
1.61B / --
EPS Revisions
Last 90 days

600422 Income Statement

FAQ

What Stock Exchange Does KPC Pharm Trade On?

KPC Pharm is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for KPC Pharm?

The stock symbol for KPC Pharm is "600422."

What Is the KPC Pharm Market Cap?

As of today, KPC Pharm market cap is 11.03B.

What Is KPC Pharm's Earnings Per Share (TTM)?

The KPC Pharm EPS (TTM) is 0.81.

When Is the Next KPC Pharm Earnings Date?

KPC Pharm will release its next earnings report on 26 Oct 2025.

From a Technical Analysis Perspective, Is 600422 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has KPC Pharm Stock Split?

KPC Pharm has split 3 times.

How Many Employees Does KPC Pharm Have?

KPC Pharm has 5275 employees.

What is the current trading status of KPC Pharm (600422)?

As of 11 Aug 2025, KPC Pharm (600422) is trading at a price of 14.52, with a previous close of 14.57. The stock has fluctuated within a day range of 14.51 to 14.58, while its 52-week range spans from 11.92 to 18.64.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.